Stigmatizing harm reduction through language: A case study into the use of "addict" and opposition to supervised injection sites in Canada

Journal of Addictions Nursing

Volumn 24, Issue 2, 2013, Pages 102-107

  Cortina, Sandra C ^a  

^a InSite (Supervised Injection Site)   (Canada)

Author keywords

Addict; Harm reduction; Stigma; Supervised injection site

Indexed keywords

ADDICTION; ADULT; ARTICLE; ATTITUDE; CANADA; CONFLICT; DRUG USE; HARM REDUCTION; HUMAN; HUMAN RIGHTS; LANGUAGE; MALE; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; SOCIAL STIGMA; STEREOTYPING;

ADULT; ATTITUDE; CANADA; DISSENT AND DISPUTES; DRUG USERS; HARM REDUCTION; HUMAN RIGHTS; HUMANS; LANGUAGE; MALE; NEEDLE-EXCHANGE PROGRAMS; PUBLIC OPINION; SOCIAL STIGMA; STEREOTYPING; SUBSTANCE-RELATED DISORDERS;

EID: 84884570240     PISSN: 10884602     EISSN: 15487148     Source Type: Journal    
DOI: 10.1097/JAN.0b013e3182929466     Document Type: Article

References (54)

1. Alderman, J., Dollar, K., & Kozlowski, L. (2010). Understanding the origins of anger, contempt, and disgust in public health policy disputes: Applying moral psychology to harm reduction debates. Journal of Public Health Policy, 31(1), 1-16.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
3. Bayoumi, A. M., Strike, C., Jairam, J.,Watson, T., Enns, E., Kolla, G.,I Brandeau, M. (2012). Report of the Toronto and Ottawa supervised consumption assessment study, 2012. Toronto, ON: St. Michael's Hospital and the Dalla Lana School of Public Health, University of Toronto. Retrieved from http://www.toscastudy.ca/toscastudy.ca/Home.html
4. Becker, H. (1963). Outsiders. Glencoe, NY: Free Press. Blackwell, T., & Alcoba,N. (2012, April 11). Ontario rejects safe injection sites. The National Post. Retrieved from http://news.nationalpost .com/2012/04/11/ontario- rejects-safe-injection-sites
5. Brener, L., Hippel, W., Kippax, S., & Preacher, K. J. (2010). The role of physician and nurse attitudes in the health care of injecting drug users. Substance Use & Misuse, 45(7-8), 1007-1018.
6. Corrigan, P.W., Kuwabara, S. A., & O'Shaughnessy, J. (2009). The public stigma of mental illness and drug addiction: Findings from a stratified random sample. Journal of Social Work, 9(2), 139-147.
7. Crocker, J.,Major, B., & Steele,C. (1998). Social stigma InD.Gilbert, S. T. Fiske, & G. E. Lindzey (Eds.), The handbook of social psychology (pp. 504-553). New York, NY: McGraw-Hill.
8. Cruz, M., Patra, J., Fischer, B., Rehm, J., & Kalousek, K. (2007). Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. The International Journal On Drug Policy, 18(1), 54-61
9. Cunningham, J. A., Sobell, L.C., & Chow, V. M. (1993).What's in a label? The effects of substance types and labels on treatment considerations and stigma. Journal of Studies on Alcohol, 54(6), 693-699.
10. Dean, J. C., & Rud, F. (1984). The drug addict and the stigma of addiction. International Journal of Addictions, 19(8), 859-869.
11. Des Jarlais, D., Arasteh, K., & Hagen, H. (2008). Evaluating Vancouver's supervised injection facility: Data and dollars, symbols and ethics. Canadian Medical Association Journal, 179(11), 1105-1106.
12. Dolan,K., Kimber, J., Fry, C., Fitzgerald, J.,McDonald, D., & Frautmann, F. (2000). Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Review, 19, 337-346.
13. Drucker, E. (1999). Drug prohibition and public health: 25 years of evidence. Public Health Reports, 114, 14-29.
14. Erickson, P. (1999). Introduction: the three phases of harmreduction. An examination of emerging concepts, methodologies, and critiques. Substance Use and Misuse, 34(1), 1-7.
15. Estroff, S. E. (1989). Self, identity and subjective experiences of schizophrenia: In search of the subject. Schizophrenia Bulletin, 15, 189-196.
16. Fine, M., & Asch, A. (1988). Disability beyond stigma: Social interaction, discrimination, and activism. Journal of Social Issues, 44, 3-22.
17. Finnigan, F. (1996). How non-heroin users perceive heroin users and how heroin users perceive themselves. Addiction Research, 4(1), 25-32.
18. Fiske, S. T., & Taylor, S. E. (1991). Social cognition (2nd ed.). New York, NY: McGraw-Hill.
19. Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. New York, NY: Simon and Scuster/Touchstone Books.
20. Harris, L. T., & Fiske, S. (2006). Dehumanizing the lowest of the low. Psychological Science, 17, 847-853.
21. Hathaway, A. (2001) Shortcomings of harm reduction: Towards a morally invested drug reform strategy. International Journal of Drug Policy, 12(2), 125-137.
22. Hathaway, A., & Tousaw, T. (2008). Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver. International Journal of Drug Policy, 19(1), 11-16.
23. Hedrich, D. (2004). European report on drug consumption rooms. Lisbon, Portugal: EuropeanMonitoring Centre for Drugs andDrug Addiction.
24. Hopson, R. E. (1996). The 12-step program. In E. P. Shafranske, (Ed.) Religion and the clinical practice of psychology (pp. 533-558). Washington, DC: American Psychological Association.
25. Inciardi, J. A., & Harrison, L. D. (2000). Harm reduction: National and international perspectives. Thousand Oaks, CA: Sage. Jackson, E. (2012, April 11). Ottawa police don't support safe injection sites for city. YourOttawaregion.com. Retrieved from http://www .yourottawaregion.com/news/ article/1334143Yottawa-police-don-tsupport-safe-injection-sites-for-city
26. Kailes, J. (1985). Watch your language, please! Journal of Rehabilitation, 51(1), 68-69.
27. Levine, H. G. (1978). The discovery of addiction: Changing conceptions of habitual drunkenness in America. Journal of Studies on Alcohol, 19(1), 143-174.
28. Link, B.G., Cullen, F. T., Struening, E., & Shrout, P. E. (1989). Amodified labeling theory approach to mental disorders: An empirical assessment. American Sociological Review, 54, 400-423.
29. Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27, 363-385.
30. MacCoun, R. (1998). Toward a psychology of harmreduction. American Psychologist, 53(11), 1199-1208.
31. Marlatt, G. A., Larimer,M. E., & Witkiewitz, K. (2011). Harm reduction: Pragmatic strategies for managing high-risk behaviors (2nd ed.). New York, NY: Guildford Press.
32. McPherson, S., & Armstrong, D. (2009). Negotiating depression labels in primary care. Social Science and Medicine, 69, 1137-1143.
33. Pan, Z., & Kosicki, G. M. (1993). Framing analysis: An approach to news discourse. Political Communication, 10, 55-75.
34. Poisson, J. (2012, April 12). Residents mixed on supervised injection clinics. The Toronto Star. Retrieved from http://www.healthzone.ca/health/ article/1160049Yresidents-mixed-on-supervised-injectionclinics
35. Public Health Agency of Canada. (2006). Leading cause of death and hospitalization in Canada. Ottawa, ON: Author. Retrieved from http://www.phac-aspc.gc.ca/publicat/lcd-pcd97/index-eng.php
36. Room, R. (2003). The cultural framing of addiction. Janus Head, 6(2), 221-234.
37. Rosenberg, H., & Phillips, K. T. (2003). Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors, 17(3), 203-210.
38. Scheff, T. (1966). The labeling theory of mental illness. American Sociological Review, 39, 444-452.
39. Skitka, L. J., & Tetlock, P. E. (1993). Providing public assistance: Cognitive and motivational processes underlying liberal and conservative policy preferences. Journal of Personality and Social Psychology, 65(6), 1205-1223.
40. Small, D. (2008). Fighting addiction's death row: British Columbia supreme court justice Ian Pitfield shows a measure of legal courage. Harm Reduction, 5, 31.
41. Small, D., Palepu, A., & Tyndall, M. (2004). The establishment of North America's first state sanctioned supervised injection facility: A case study in culture change. The International Journal of Drug Policy, 17, 73-82.
42. Spear B. (1994). The early years of the "British system" in practice In J. Strang, & M. Gossop (Eds.), Heroin addiction and drug policy: The British system (pp. 3-28). Oxford, UK: Oxford University Press.
43. Stanbrook,M. B. (2012).Addiction is a disease:We must change our attitudes towards addicts. Canadian Medical Association Journal, 184(2), 155.
44. Stepney, R. (1996). The concept of addiction: Its use and abuse in the media and science. Human Psychopharmacology: Clinical and Experimental, 11(Suppl. 1), S15YS20.
45. Strathdee, S. A., Patrick, D. M., Currie, S., Cornelisse, P. G., Rekart, M., Montaner, J. S.,I O'Shaughnessy, M. V. (1997) Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11(8), F59YF65.
46. Substance Abuse and Mental Health Services Administration. (1996). Stigma and mental illness. Retrieved from http://www.ctclearinghouse .org/topics/customer-files/Stigma-and-Mental-Illness-061305.pdf
47. vanHaastrecht, H. (1997).HIV infection and drug use in the Netherlands: The course of the epidemic. Journal of Drug Issues, 27, 57-72.
48. Wahl, O. F. (2004). Stop the presses. Journalistic treatment of mental illness. In L. D. Friedman (Ed.), Cultural sutures. Medicine and media (pp. 55-69). Durkheim, NC: Duke University Press.
49. Watson, T. M., Bayoumi, A., Kolla, G., Penn, R., Fischer, B., Luce, J., & Strike, C. (2012). Police perceptions of supervised consumption sites (SCSs): A qualitative study. Substance Use andMisuse, 47(4), 364-374.
50. Weiner, B., Perry, R. P., & Magnusson, J. (1988). An attributional analysis of reactions to stigmas. Journal of Personality Social Psychology, 55(5), 738-748.
51. Wodak, A., Symonds, A., & Richmond, R. (2003). The role of civil disobedience in drug policy reform: How an illegal safer injection room led to a sanctioned medically supervised injection center. Journal of Drug Issues, 3, 609-623.
52. Wood, E, Tyndall,M.W.,Montaner, J. S., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal, 175(11), 1399-1404.
53. World Health Organization. (2008). ICD-10: International statistical classification of diseases and related health problems (10th rev. ed.). New York, NY: Author.
54. Wurmser, L. (1978). The hidden dimension: The psychodynamics of compulsive drug use. Northvale, NJ: Jason Aronson.